US Stock MarketDetailed Quotes

ALXO ALX Oncology

Watchlist

1.810
+0.250+16.03%

Close Jan 3 16:00 ET

1.790
-0.020-1.10%

Post 20:01 ET

95.47MMarket Cap-0.61P/E (TTM)

ALX Oncology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

ALX Oncology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	0.000 / 0.000	--
--	2024/Q2	0.000 / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q30.000 / 0.000--

--2024/Q20.000 / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

ALX Oncology Earnings Reports

ALX Oncology | 8-K: ALX Oncology Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Nov 7, 2024 16:11 ET

ALX Oncology | 10-Q: Q3 2024 Earnings Report

Nov 7, 2024 16:09 ET

ALX Oncology | 10-Q: Q2 2024 Earnings Report

Aug 12, 2024 16:08 ET

ALX Oncology | 8-K: ALX Oncology Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 8, 2024 16:15 ET

Analyst Rating

Updated: Jan 3, 2025

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall